I just read the quarterly and its ok and mostly expected in the current market turmoil.
Shareholders have been advised previously that it would take some time to be profitable as they scale up (estimated end of 2020) so its no surprise.
T12 has seen a "Drastic Increase" in demand since COVID19 ..
New T12 products coming to the International market soon are Buckwheat, Millet and Others...(Brown Rice?)
No news on Bauxite is good news(?) hopefully and they will wind it up at EOFY.
CGB/Pharmocann product release in the next 30-60days hopefully.
Canntab final approval is about the only thing that might have a chance of turning things around in the short/medium term imo
The next quarterly is only 86 days away..not long now ... Meh!
